SCHEMBL30033426

SCHEMBL30033426

CC(C)c1ccc2[nH]c(=O)n(-c3cncc4ccccc34)c(=O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPEPPS P55786 2/20 0.43
▸ KDM4E B2RXH2 4/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ KIF11 P52732 1/20 0.39
▸ HAVCR2 Q8TDQ0 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30034219 0.91 NPEPPS (0.43) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30033441 0.89 NPEPPS (0.40) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30032977 0.89 NPEPPS (0.40) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL31509793 0.83 NPEPPS (0.57) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30032168 0.83 NPEPPS (0.49) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30033042 0.83 KDM4E (0.57) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30034581 0.82 HSD17B10 (0.58) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30034171 0.81 NPEPPS (0.43) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30033277 0.81 NPEPPS (0.43) NPEPPSKDM4EHTTHSD17B10PKM
SCHEMBL30033413 0.81 KIF11 (0.46) NPEPPSKDM4EHTTHSD17B10PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback